Connection

Pablo Barreiro to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Pablo Barreiro has written about Antiviral Agents.
Pablo Barreiro
Connection Strength
0.296
Antiviral Agents
  1. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections. AIDS Rev. 2020 07 08; 22(2):124-127.
    View in: PubMed
    Score: 0.082
  2. Treatment of hepatitis C with new fixed dose combinations. Expert Opin Pharmacother. 2017 Aug; 18(12):1235-1242.
    View in: PubMed
    Score: 0.067
  3. Drug interactions in HIV-infected patients treated for hepatitis C. Expert Opin Drug Metab Toxicol. 2017 Aug; 13(8):807-816.
    View in: PubMed
    Score: 0.067
  4. Is Ribavirin Teratogenic in Humans? No Evidence So Far. Drug Saf. 2017 12; 40(12):1163-1165.
    View in: PubMed
    Score: 0.017
  5. Need to Face Liver Cirrhosis after HCV Cure with Antivirals. EBioMedicine. 2017 10; 24:24-25.
    View in: PubMed
    Score: 0.017
  6. New antivirals for the treatment of chronic hepatitis B. Expert Opin Investig Drugs. 2017 Jul; 26(7):843-851.
    View in: PubMed
    Score: 0.017
  7. Hepatitis delta and HIV infection. AIDS. 2017 04 24; 31(7):875-884.
    View in: PubMed
    Score: 0.016
  8. Update on the treatment of chronic hepatitis C in HIV-infected patients. AIDS Rev. 2007 Apr-Jun; 9(2):99-113.
    View in: PubMed
    Score: 0.008
  9. Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C. Expert Opin Drug Metab Toxicol. 2017 Sep; 13(9):1015-1022.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.